Ever Supreme Bio Technology Co., Ltd

NT$144.50As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6712Healthcare
Country Taiwan
PE (Fwd) •••
TSR 8Y CAGR 13.14%
Div yield 2.31%
ROE 23.35%
Biotechnology
Beta (5Y) 0.32
PE TTM 29.51
TSR TTM (3.70%)
Mkt cap NT$14.56B
ROIC 21.08%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$141
(2.40%)
(29.68%)
Hold 7|10|2|0|7
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
1.80
1.71
1.80
1.95
25.43%
12.14%
7.67%
6.46%
RevenueNT$M
657.5
688.2
720.5
722.0
2.90%
9.25%
16.15%
15.30%
Peers (US$439.6M)
Cap (US$)
PE
423.0M
—
422.9M
1,362x
440.2M
212.0x
Capital
TTM
5Y
10Y
Leveragex
16.11
(0.153)
(0.116)
EBIT/Intx
0.577
0.612
0.554
Own earn%
(71.08)
23.14
22.51
Sh yield%
26.82
7.25
7.74
Owners
Insiders/Inst%
1.96
37.72
Short interest%
1.42
SBC / revenue%
5.47
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
23–26
$1 testx
0.1
Incr. ROIC%
2